Keytruda Gets a New Job

[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has granted accelerated approval to pembrolizumab (brand name Keytruda) for patients with classical Hodgkin lymphoma (cHL). Pembrolizumab was approved for

Read More